Emergent Biosolutions Inc (NYSE:EBS) shares, rose in value on Thursday, March 27, with the stock price down by -4.84% to the previous day’s close as strong demand from buyers drove the stock to $4.92.
Actively observing the price movement in the last trading, the stock closed the session at $5.17, falling within a range of $4.64 and $5.1664. The value of beta (5-year monthly) was 1.802. Referring to stock’s 52-week performance, its high was $15.10, and the low was $1.82. On the whole, EBS has fluctuated by -32.32% over the past month.
With the market capitalization of Emergent Biosolutions Inc currently standing at about $267.34 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Mar-02.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 825M, with a low estimate of 200M and a high estimate of 237M. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 218.5M.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that EBS’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium-term indicators have put the stock in the category of 100% Sell while long-term indicators on average have been pointing out that it is a 75% Sell.
The stock’s technical analysis shows that the price of EBS currently trading nearly -15.70% and -39.59% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 26.14, while the 7-day volatility ratio is showing 6.59% which for the 30-day chart, stands at 8.97%. Furthermore, Emergent Biosolutions Inc (EBS)’s beta value is 2.12, and its average true range (ATR) is 0.47.
A comparison of Emergent Biosolutions Inc (EBS) with its peers suggests the former has fared considerably weaker in the market. EBS showed an intraday change of -4.84% in last session, and over the past year, it grew by 93.70%%.
Data on historical trading for Emergent Biosolutions Inc (NYSE:EBS) indicates that the trading volumes over the past 10 days have averaged 1.02 and over the past 3 months, they’ve averaged 1.17 million. According to company’s latest data on outstanding shares, there are 54.30 million shares outstanding.
Nearly 3.72% of Emergent Biosolutions Inc’s shares belong to company insiders and institutional investors own 63.92% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 8.14 million shares as on 2025-02-28, resulting in a short ratio of 7.88. According to the data, the short interest in Emergent Biosolutions Inc (EBS) stood at 1818.00 of shares outstanding as of 2025-02-28; the number of short shares registered in 2025-01-31 reached 6.93 million. The stock has fallen by -48.54% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the EBS stock heading into the next quarter.
